Pacific Biosciences of California (NASDAQ:PACB) Price Target Cut to $2.00 by Analysts at Scotiabank
Pacific Biosciences of California (NASDAQ:PACB – Get Free Report) had its price objective lowered by analysts at Scotiabank from $6.00 to $2.00 in a research note issued on Tuesday,Benzinga reports.
Cathie Wood’s ARK Investment bought 415K shares of PacBio today
EDT Cathie Wood’s ARK Investment bought 415K shares of PacBio (PACB) todayLight Up your Portfolio with Spark:Easily identify stocks' ...
Assessing Pacific Biosciences: Insights From 6 Financial Analysts
Analysts provide deeper insights through their assessments of 12-month price targets, revealing an average target of $2.04, a high estimate of $2.50, and a low estimate of $1.50.
PacBio price target lowered to $2 from $6 at Scotiabank
Scotiabank analyst Sung Ji Nam lowered the firm’s price target on PacBio (PACB) to $2 from $6 and keeps an Outperform rating on the shares. The ...